MX2021013302A - Nucleasas programables y metodos de uso. - Google Patents

Nucleasas programables y metodos de uso.

Info

Publication number
MX2021013302A
MX2021013302A MX2021013302A MX2021013302A MX2021013302A MX 2021013302 A MX2021013302 A MX 2021013302A MX 2021013302 A MX2021013302 A MX 2021013302A MX 2021013302 A MX2021013302 A MX 2021013302A MX 2021013302 A MX2021013302 A MX 2021013302A
Authority
MX
Mexico
Prior art keywords
methods
programmable
programmable nucleases
nucleases
nuclease
Prior art date
Application number
MX2021013302A
Other languages
English (en)
Spanish (es)
Inventor
Lucas Benjamin Harrington
Janice Sha Chen
Isaac Paterson Witte
Original Assignee
Mammoth Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mammoth Biosciences Inc filed Critical Mammoth Biosciences Inc
Publication of MX2021013302A publication Critical patent/MX2021013302A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
MX2021013302A 2019-05-01 2020-05-01 Nucleasas programables y metodos de uso. MX2021013302A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962841770P 2019-05-01 2019-05-01
PCT/US2020/031030 WO2020223634A1 (en) 2019-05-01 2020-05-01 Programmable nucleases and methods of use

Publications (1)

Publication Number Publication Date
MX2021013302A true MX2021013302A (es) 2022-01-31

Family

ID=70802945

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021013302A MX2021013302A (es) 2019-05-01 2020-05-01 Nucleasas programables y metodos de uso.

Country Status (8)

Country Link
US (2) US20220049241A1 (cg-RX-API-DMAC7.html)
EP (1) EP3963069A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022530981A (cg-RX-API-DMAC7.html)
CN (1) CN114174508A (cg-RX-API-DMAC7.html)
AU (1) AU2020265256A1 (cg-RX-API-DMAC7.html)
CA (1) CA3134934A1 (cg-RX-API-DMAC7.html)
MX (1) MX2021013302A (cg-RX-API-DMAC7.html)
WO (1) WO2020223634A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3121247A1 (en) 2018-12-03 2020-06-11 Board Of Regents, The University Of Texas System Oligo-benzamide analogs and their use in cancer treatment
KR20230076820A (ko) 2020-09-01 2023-05-31 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 진핵생물 유전체 공학을 위한 합성 미니어처 crispr-cas(casmini) 시스템
WO2022241032A1 (en) * 2021-05-12 2022-11-17 Mammoth Biosciences, Inc. Enhanced guide nucleic acids and methods of use
US20250345460A1 (en) * 2021-05-14 2025-11-13 Genkore Inc. Composition and method for treatment of lca10 using rna-guided nuclease
AU2022284804A1 (en) 2021-06-01 2023-12-07 Arbor Biotechnologies, Inc. Gene editing systems comprising a crispr nuclease and uses thereof
WO2023283622A1 (en) 2021-07-08 2023-01-12 Montana State University Crispr-based programmable rna editing
US11814689B2 (en) 2021-07-21 2023-11-14 Montana State University Nucleic acid detection using type III CRISPR complex
JP2025507822A (ja) 2022-03-01 2025-03-21 エピクリスパー バイオテクノロジーズ, インコーポレイテッド 組換えヌクレアーゼならびにその組成物および使用方法
US20260232844A1 (en) 2023-02-15 2026-08-13 Arbor Biotechnologies, Inc. Gene editing method for inhibiting aberrant splicing in stathmin 2 (stmn2) transcript
WO2025171210A1 (en) 2024-02-09 2025-08-14 Arbor Biotechnologies, Inc. Compositions and methods for gene editing via homology-mediated end joining
WO2026015829A2 (en) 2024-07-12 2026-01-15 Arbor Biotechnologies, Inc. Small reverse transcriptases and gene editing systems comprising such
WO2026015832A2 (en) 2024-07-12 2026-01-15 Arbor Biotechnologies, Inc. Reverse transcriptases and gene editing systems comprising such

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117487776A (zh) * 2017-11-01 2024-02-02 加利福尼亚大学董事会 Casz组合物和使用方法

Also Published As

Publication number Publication date
US20220049241A1 (en) 2022-02-17
CN114174508A (zh) 2022-03-11
WO2020223634A1 (en) 2020-11-05
JP2022530981A (ja) 2022-07-05
AU2020265256A1 (en) 2021-12-23
CA3134934A1 (en) 2020-11-05
US20240191224A1 (en) 2024-06-13
EP3963069A1 (en) 2022-03-09

Similar Documents

Publication Publication Date Title
HK1257676A1 (zh) 工程化 crispr-cas 9 核酸酶
ZA202105751B (en) Fermentation broths and their use
PT3765616T (pt) Novas enzimas e sistemas de direcionamento de dna e rna crispr
GB2569734A (en) RNA-guided nucleic acid modifying enzymes and methods of use thereof
PT3765615T (pt) Novas enzimas e sistemas de direcionamento de dna crispr
PH12019500281A1 (en) Regulation of gene expression using engineered nucleases
GB2542653A (en) Methods and compositions for treating cells for transplant
IL291095A (en) Novel crispr dna targeting enzymes and systems
GB2544001A (en) Methods for increasing Cas9-mediated engineering efficiency
AR113154A1 (es) Polinucleótidos, composiciones y métodos para edición del genoma
IL287320B (en) Integrative single-cell and cell-free plasma RNA analysis
WO2017180915A3 (en) Crispr/cas9-based repressors for silencing gene targets in vivo and methods of use
MY207856A (en) Article for use with apparatus for heating smokable material
EP3265559A4 (en) Engineered crispr-cas9 nucleases with altered pam specificity
SG11202102106RA (en) Cellulose-synthase-like enzymes and uses thereof
SG10201810150UA (en) Compositions and methods for enhanced gene expression in cone cells
EP3617309A3 (en) Crispr-based genome modification and regulation
AU365451S (en) Grilling apparatus
MX2019004156A (es) Variantes de endonucleasa homing de receptor de linfocitos t alfa (tcralpha).
IL280728B1 (en) Mixtures of microorganisms, molecules derived from them, and their use
WO2016134213A3 (en) Enhanced protein expression
MX2018010023A (es) Lipasas para hornear.
AU201812086S (en) Thermoventilator
EP3460050A4 (en) CELL RENTAL PROCESS, CULTURAL MEDIUM AND CULTURE MEDIUM KIT
EP3158077A4 (en) Cell culture methods and media comprising n-acetylcysteine